Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2021Science AdvancesOpen Access

Switchable immune modulator for tumor-specific activation of anticancer immunity

View Full Paper
Ask AI
Bookmark
Share

Authors

YZYu ZhaoDalian University of TechnologyYXYuqing XieETH ZurichSHSimon Van HerckCornell University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhao et al. (2021) studied this question.

synapsesocial.com/papers/6a87cff019ee2aac066c88b4https://doi.org/10.1126/sciadv.abg7291
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine2018 · 281 citations
  2. 2Cytokine-Mediated Disruption of Lymphocyte Trafficking, Hemopoiesis, and Induction of Lymphopenia, Anemia, and Thrombocytopenia in Anti-CD137-Treated Mice2007 · 171 citations
  3. 3Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity2018 · 146 citations
  4. 4Immune Responses in the Liver2018 · 929 citations
  5. 5Photocontrolled Targeted Drug Delivery: Photocaged Biologically Active Folic Acid as a Light‐Responsive Tumor‐Targeting Molecule2012 · 203 citations